Search
Menu
Hamamatsu Corp. - Earth Innovations LB 2/24

Stanford University

Facebook X LinkedIn Email
Stanford University of Palo Alto, Calif., and the Berlin-based Schering AG of the Bayer Group of Leverkusen, Germany, have entered into a joint research program to identify PET tracers for tumor imaging. Schering will have the option to assume exclusive rights to develop and commercialize such tracers, which could enable early detection of pathological changes in the body.
Lumencor Inc. - ZIVA Light Engine 3-24 MR

Published: January 2007
BiophotonicsNews & Featurespathological changesPET tracersStanford University

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.